✨ Medicines and Aquaculture Notices
NEW ZEALAND GAZETTE, No. 128 — 26 NOVEMBER 2015
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Boostrix
Active Ingredients:
Diphtheria toxoid, adsorbed 2IU
Pertactin 2.5mcg
Pertussis filamentous haemagglutinin 8mcg
Pertussis toxoid, adsorbed 8mcg
Tetanus toxoid, adsorbed 20IU
Dosage Form:
Suspension for injection
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
GlaxoSmithKline Biologicals (Saint-Amand-Les-Eaux), Saint-Amand-Les-Eaux, France
Product:
DBL™ Mitoxantrone Hydrochloride Injection Concentrate
Active Ingredient:
Mitoxantrone hydrochloride 2.33mg/mL equivalent to Mitoxantrone 2mg/mL
Dosage Form:
Concentrate for infusion
New Zealand Sponsor:
Hospira NZ Limited
Manufacturers:
Hospira Australia Pty Limited, Melbourne, Australia
Zydus Hospira Oncology Limited (ZHOPL), Ahmedabad, India
Product:
Simponi
Active Ingredient:
Golimumab 50mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturer:
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America
Product:
Simponi SmartJect Injector
Active Ingredient:
Golimumab 50mg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturer:
Baxter Pharmaceutical Solutions LLC, Indiana, United States of America
Dated this 20th day of November 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Maori Commercial Aquaculture Claims Settlement (Extension to Negotiation Periods for Canterbury, Southland and Wellington) Notice 2015 (Notice No. MPI 563)
Pursuant to section 11(3) of the Maori Commercial Aquaculture Claims Settlement Act 2004 ("the Act"), the Minister for Primary Industries, after complying with the requirements in section 11(4) of that Act, gives the following notice.
Notice
- Title and commencement—(1) This notice may be cited as the Maori Commercial Aquaculture Claims Settlement (Extension to Negotiation Periods for Canterbury, Southland and Wellington) Notice 2015.
(2) This notice comes into force on 30 November 2015.
- Interpretation—In this notice:
Next Page →
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare20 November 2015
Medicines, Boostrix, DBL™ Mitoxantrone Hydrochloride Injection Concentrate, Simponi, Medicines Act 1981
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
🪶 Maori Commercial Aquaculture Claims Settlement (Extension to Negotiation Periods for Canterbury, Southland and Wellington) Notice 2015
🪶 Māori AffairsAquaculture, Settlement, Negotiation Periods, Canterbury, Southland, Wellington
NZ Gazette 2015, No 128